Crispr Therapeutics AG Stock (CRSP)

Track Crispr Therapeutics AG stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, Action Alerts PLUS portfolio activity, contributor watchlist signals, and Pro price levels.

$55.68

▲ +15.96 (+42.48%) past year

Live · Updated May 28, 5:24 PM

Market Cap

$4.98B

P/E Ratio

—

1Y Return

+42.48%

EPS (TTM)

-$6.21

Read the latest TheStreet Pro articles mentioning Crispr Therapeutics AG, including market roundups, portfolio updates, trade ideas, and investing analysis.

Articles

2 articles

trade-ideas Sure, a Rally's Possible, but I'd Rather See Downside First
Helene MeislerAug 7, 2025
CRSP TSLA EVLV
market-commentary Of Cathie Wood's 10 Largest Positions, One Stock Stands Out From the Rest
James "Rev Shark" DePorreApr 4, 2024
CRSP DKNG TSLA

Daily Diary Mentions

0 mentions

No diary mentions for CRSP yet.